Alphyn Biologics has filed a notice of an exempt offering of securities to raise $5,172,484.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, Alphyn Biologics is raising up to $5,172,484.00 in new funding. Sources indicate that as part of senior management Chairman and Chief Executive Officer, Neal Koller…
